The Implications of Drug-Polymer Interactions on the Physical Stability of Amorphous Solid Dispersions

Pharm Res. 2023 Dec;40(12):2963-2981. doi: 10.1007/s11095-023-03547-4. Epub 2023 Jun 30.

Abstract

Amorphous solid dispersions (ASDs) are a formulation and development strategy that can be used to increase the apparent aqueous solubility of poorly water-soluble drugs. Their implementation, however, can be hindered by destabilization of the amorphous form, as the drug recrystallizes from its metastable state. Factors such as the drug-polymer solubility, miscibility, mobility, and nucleation/crystal growth rates are all known to impact the physical stability of an ASD. Non-covalent interactions (NCI) between the drug and polymer have also been widely reported to influence product shelf-life. In this review, the relationship between thermodynamic/kinetic factors and adhesive NCI is assessed. Various types of NCIs reported to stabilize ASDs are described, and their role in affecting physical stability is examined. Finally, NCIs that have not yet been widely explored in ASD formulations, but may potentially impact their physical stability are also briefly described. This review aims to stimulate further theoretical and practical exploration of various NCIs and their applications in ASD formulations in the future.

Keywords: amorphous solid dispersions; drug-polymer interactions; physical stability; thermodynamic and kinetic factors; σ-hole interactions.

Publication types

  • Review

MeSH terms

  • Crystallization
  • Drug Compounding
  • Drug Stability
  • Polymers* / chemistry
  • Solubility
  • Thermodynamics

Substances

  • Polymers